Log In
Print this Print this

Sclerostin antibody (AMG 167)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionMAb against sclerostin
Molecular Target Sclerostin
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Musculoskeletal (unspecified)
Indication DetailsPrevent bone loss during space flight
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today